Altimmune

$14.65
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) As of 2:40 PM UTC today

Why Robinhood?

You can buy or sell Altimmune and other stocks, options, and ETFs commission-free!

About ALT

Altimmune, Inc. Common Stock, also called Altimmune, is a clinical stage immunotherapeutic biotechnology company. It focuses on the discovery and development of products to stimulate robust and durable immune responses for the prevention and treatment of diseases. The company's portfolio includes RespirVec and Densigen that targets to stimulate the elements of the human immune system to treat respiratory diseases, chronic infections, and cancer. Altimmune was founded in 1997 and is headquartered in Gaithersburg, MD. The listed name for ALT is Altimmune, Inc. Common Stock.

CEO

Vipin K. Garg

Employees

Headquarters

Gaithersburg, Maryland

Founded

1997

Market Cap

502.95M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

1.39M

High Today

$15.15

Low Today

$14.70

Open Price

$14.80

Volume

237.49K

52 Week High

$35.10

52 Week Low

$1.60

Collections

ALT Earnings

-$0.94

-$0.63

-$0.31

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 26, After Hours